Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
Saved in:
| Title: | Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme. |
|---|---|
| Authors: | De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola, Italy., Cartenì G; Department of Medical Oncology, Azienda Ospedaliero-Universitaria 'A. Cardarelli', Napoli, Italy., Giannarelli D; Department of Statistics, Regina Elena National Cancer Institute - IRCCS, Rome, Italy., Basso U; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy., Galli L; Department of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Spedali Riuniti S. Chiara, Pisa, Italy., Cortesi E; Department of Medical Oncology, Policlinico Umberto I, Roma, Italy., Caserta C; Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Santa Maria, Terni, Italy., Pignata S; Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italy., Sabbatini R; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy., Bearz A; Department of Medical Oncology, Istituto Nazionale Tumori - IRCCS, Aviano, Italy., Buti S; Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Lo Re G; Department of Medical Oncology, CRO Pordenone-S.Vito Oncology, CRO - IRCCS, Aviano, Italy., Berruti A; Department of Medical Oncology, ASST Spedali Civili di Brescia, Brescia, Italy., Bracarda S; Department of Medical Oncology, Azienda USL 8, Arezzo, Italy., Cognetti F; Department of Medical Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy., Rastelli F; Department of Medical Oncology, Fermo Area Vasta 4, Fermo, Italy., Fornarini G; Department of Medical Oncology, Azienda Ospedaliero-Universitaria San Martino IST - IRCCS, Genova, Italy., Porta C; University of Pavia and IRCCS San Matteo University Hospital Foundation, Pavia, Italy.; IRCCS San Matteo University Hospital Foundation, Pavia, Italy., Turci D; Department of Medical Oncology, Ospedale Santa Maria delle Croci, Ravenna, Italy., Sternberg CN; Department of Medical Oncology, San Camillo Forlanini Hospital, Roma, Italy., Procopio G; Department of Medical Oncology, Istituto Nazionale Tumori - IRCCS, Milano, Italy. |
| Corporate Authors: | Italian Nivolumab Renal Cell Cancer Early Access Program Group |
| Source: | BJU international [BJU Int] 2019 Jan; Vol. 123 (1), pp. 98-105. Date of Electronic Publication: 2018 Jul 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
